Current Issue May 2012, Vol. 13, No. 3

Issue Highlights

  • Systematic Review of the Cost-Effectiveness of Positron-Emission Tomography in Staging of Non–Small-Cell Lung Cancer and Management of Solitary Pulmonary Nodules
    May 2012(Vol. 13 | No. 3 | Pages 161-170)

    Jeffrey Q. Cao, George B. Rodrigues, Alexander V. Louie, Gregory S. Zaric

  • Epothilones in Development for Non–Small-Cell Lung Cancer: Novel Anti-Tubulin Agents With the Potential to Overcome Taxane Resistance
    May 2012(Vol. 13 | No. 3 | Pages 171-180)

    Martin J. Edelman, Marianna Shvartsbeyn

  • Role of Positron Emission Tomography in the Early Prediction of Response to Chemotherapy in Patients With Non–Small-Cell Lung Cancer
    May 2012(Vol. 13 | No. 3 | Pages 181-187)

    Evangelia Skoura, Ioannis E. Datseris, Ioannis Platis, Georgios Oikonomopoulos, Konstantinos N. Syrigos

  • Novel High-Sensitive D-Dimer Determination Predicts Chemotherapy-Associated Venous Thromboembolism in Intermediate Risk Lung Cancer Patients
    17 May 2012

    Patrizia Ferroni, Francesca Martini, Ilaria Portarena, Gioia Massimiani, Silvia Riondino, Francesca La Farina, Sabrina Mariotti, Fiorella Guadagni, Mario Roselli

  • Identifying Barriers Associated With Enrollment of Patients With Lung Cancer into Clinical Trials
    17 May 2012

    Leora Horn, Vicki L. Keedy, Norma Campbell, Gabe Garcia, Amy Hayes, Brady Spencer, David P. Carbone, Alan Sandler, David H. Johnson

  • Gemcitabine and Paclitaxel Combination as Second-Line Chemotherapy in Patients With Small-Cell Lung Cancer: A Phase II Study
    27 April 2012

    Claudio Dazzi, Anna Cariello, Claudia Casanova, Alberto Verlicchi, Marco Montanari, Giorgio Papiani, Eva Freier, Valentina Mazza, Carlo Milandri, Alessandro Gamboni, Maximilian Papi, Maurizio Leoni, Giorgio Cruciani, Bernadette Vertogen

  • Diffuse Reflectance Spectroscopy: A New Guidance Tool for Improvement of Biopsy Procedures in Lung Malignancies
    26 April 2012

    Daniel J. Evers, Rami Nachabé, Houke M. Klomp, Johanna W. van Sandick, Michel W. Wouters, Gerald W. Lucassen, Benno H.W. Hendriks, Jelle Wesseling, Theo J.M. Ruers

  • Docetaxel Versus Vinorelbine in Elderly Patients With Advanced Non–Small-Cell Lung Cancer
    23 April 2012

    Athanasios Karampeazis, Vassilis Georgoulias

    • View More Articles in Press...

On the Cover


Cover Image


Editor-in-Chief:
David R. Gandara, MD

New Issue Alert

Free Trial Issue

Companion Journals

Attention Qualified Recipients

If you are a qualified recipient of the US print edition of Clinical Lung Cancer, click here to access the online edition.

Access this journal onSciVerse ScienceDirect
Print or Share This Page

About Clinical Lung Cancer

Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.

Clinical Lung Cancer is indexed by PubMed.

Journal Access

Full-text articles are available from 1999 to the present. Access to abstracts is complimentary. Access to full text is limited to personal subscribers.

Activate Online Access

Journal Ranking

Impact Factor: 2.362
© Thomson Reuters Journal Citation Reports 2010

Publishing Information

Clinical Lung Cancer is published by Elsevier.